| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ADAPY (ADAPY) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ADAPY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 100.37M | $4.01M | - | |
| COO | 986.4K | $39.5K | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2020 | Bertrand William C Jr | Chief Operating Officer | Sell | 2,397 | $5.13 | $12,307.88 | -39.9% | |
| Jan 14, 2020 | Lunger John | Chief Patient Supply Officer | Sell | 1,144 | $5.13 | $5,874.10 | -40.5% | |
| Jan 14, 2020 | Rawcliffe Adrian | Chief Executive Officer | Sell | 3,236 | $5.13 | $16,615.89 | -50.5% | |
| Jan 13, 2020 | Noble James | Director | Sell | 300,000 | $4.67 | $1,400,000.00 | -100% | |
| Jan 13, 2020 | Tayton-Martin Helen Katrina | Chief Business Officer | Sell | 100,000 | $4.50 | $450,000.00 | -100% | |
| Jan 6, 2020 | Lunger John | Chief Patient Supply Officer | Sell | 1,148 | $1.20 | $1,377.60 | -40.6% | |
| Jan 6, 2020 | Bertrand William C Jr | Chief Operating Officer | Sell | 3,731 | $1.20 | $4,477.20 | -39.8% | |
| Jan 6, 2020 | Rawcliffe Adrian | Chief Executive Officer | Sell | 5,900 | $1.20 | $7,080.00 | -50.4% | |
| Aug 6, 2019 | Amado Rafael65 | President, R&D | Sell | 11,043 | $2.06 | $22,748.58 | -39.0% | |
| Jan 14, 2019 | Binder-Scholl Gwendolyn Knowlton | Chief Technology Officer | Sell | 1,514 | $5.37 | $8,129.27 | -37.8% |